Form 6-K
 
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF THE
SECURITIES EXCHANGE ACT OF 1934
Dated November 6, 2006

 
PreMD Inc.
Commission File Number 1-31360

615-4211 Yonge Street
Toronto, Ontario M2P 2A9
CANADA
(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F

Form 20-F ý
Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____
 
Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____
 
Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant's "home country"), or under the rules of the home country exchange on which the registrant's securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant's security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.
 
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
 
Yes ¨
No ý
 
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- ________

 


PreMD Inc.
Form 6-K
 
            On November 6, 2006, the Corporation issued a news release announcing that it has submitted a premarket notification or 510(k) to the U.S. Food and Drug Administration (FDA) for clearance of PREVU* LT, the lab-processed format of the PREVU* technology. PREVU*LT is the second product in the PREVU* line of skin sterol tests and has been developed for use within the insurance industry and diagnostic laboratories. The information contained in the news release and interim report is incorporated herein by reference and filed respectively as Exhibit 99.1 hereto.
 
 
 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

 
PreMD Inc.
     
     
By:
/s/ Ronald G. Hosking
   
Ronald G. Hosking
   
Vice President and Chief Financial Officer

Date: November 6, 2006
    




EXHIBIT INDEX
 
Exhibit
 
 
Number
  
Description
     
99.1
  
The Registrant’s News Release
   
Dated November 6, 2006